Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vascular Surgery

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 50 articles:
HTML format
Text format



Single Articles


    March 2018
  1. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.
    PubMed     Text format    


  2. CAULDWELL M, Steer PJ, Bonner S, Asghar O, et al
    Retrospective UK multicentre study of the pregnancy outcomes of women with a Fontan repair.
    Heart. 2018;104:401-406.
    PubMed     Text format     Abstract available


  3. DE BELDER AJ
    Rotational atherectomy: re-emergence of an old technique.
    Heart. 2018;104:440-448.
    PubMed     Text format    


    February 2018
  4. HAYS BS, Baker M, Laib A, Tan W, et al
    Histopathological abnormalities in the central arteries and veins of Fontan subjects.
    Heart. 2018;104:324-331.
    PubMed     Text format     Abstract available


  5. AVERIN K, Byrnes JW, Benscoter DT, Whiteside W, et al
    Life-threatening airway bleeding after palliation of single ventricle congenital heart disease.
    Heart. 2018;104:254-260.
    PubMed     Text format     Abstract available


  6. LATUS H, Nassar MS, Wong J, Hachmann P, et al
    Ventricular function and vascular dimensions after Norwood and hybrid palliation of hypoplastic left heart syndrome.
    Heart. 2018;104:244-252.
    PubMed     Text format     Abstract available


    January 2018
  7. ARRI SS, Patterson T, Williams RP, Moschonas K, et al
    Myocardial revascularisation in high-risk subjects.
    Heart. 2018;104:166-179.
    PubMed     Text format    


  8. MAZNYCZKA AM, McCartney P, Berry C
    Reference invasive tests of microvascular injury in myocardial infarction.
    Heart. 2018;104:90-92.
    PubMed     Text format    


  9. DE WAARD GA, Fahrni G, de Wit D, Kitabata H, et al
    Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction.
    Heart. 2018;104:127-134.
    PubMed     Text format     Abstract available


    December 2017
  10. QUANDT D, Ramchandani B, Penford G, Stickley J, et al
    Right ventricular outflow tract stent versus BT shunt palliation in Tetralogy of Fallot.
    Heart. 2017;103:1985-1991.
    PubMed     Text format     Abstract available


  11. GNANENTHIRAN SR, Kritharides L, D'Souza M, Lowe HC, et al
    Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.
    Heart. 2017;103:1962-1969.
    PubMed     Text format     Abstract available


  12. DE CARLO M, Liga R
    Elderly patients with non-ST-elevation acute coronary syndromes: a call for action.
    Heart. 2017;103:1932-1933.
    PubMed     Text format    


    November 2017
  13. GRAY AM, Murphy J, Altman DG, Benedetto U, et al
    One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.
    Heart. 2017;103:1719-1726.
    PubMed     Text format     Abstract available


  14. TANG E, Wei ZA, Whitehead KK, Khiabani RH, et al
    Effect of Fontan geometry on exercise haemodynamics and its potential implications.
    Heart. 2017;103:1806-1812.
    PubMed     Text format     Abstract available


  15. EGBE AC, Khan AR, Ammash NM, Barbara DW, et al
    Predictors of procedural complications in adult Fontan patients undergoing non-cardiac procedures.
    Heart. 2017;103:1813-1820.
    PubMed     Text format     Abstract available


    October 2017
  16. OHUCHI H, Negishi J, Hayama Y, Miyazaki A, et al
    Renal resistive index reflects Fontan pathophysiology and predicts mortality.
    Heart. 2017;103:1631-1637.
    PubMed     Text format     Abstract available


    September 2017
  17. BUTTAR SN, Yan TD, Taggart DP, Tian DH, et al
    Long-term and short-term outcomes of using bilateral internal mammary artery grafting versus left internal mammary artery grafting: a meta-analysis.
    Heart. 2017;103:1419-1426.
    PubMed     Text format     Abstract available


  18. NAIROOZ R, Saad M, Elgendy IY, Mahmoud AN, et al
    Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: a meta-analysis of randomised trials.
    Heart. 2017;103:1427-1434.
    PubMed     Text format     Abstract available


    August 2017
  19. ALFREDSSON J, Neely B, Neely ML, Bhatt DL, et al
    Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
    Heart. 2017;103:1168-1176.
    PubMed     Text format     Abstract available


    July 2017
  20. KURLANSKY PA
    Arterial grafting for coronary revascularisation and the illusive search for truth.
    Heart. 2017 Jul 12. pii: heartjnl-2017-311289. doi: 10.1136/heartjnl-2017-311289
    PubMed     Text format    


  21. UDINK TEN CATE FEA, Trieschmann U, Germund I, Hannes T, et al
    Stenting the Fontan pathway in paediatric patients with obstructed extracardiac conduits.
    Heart. 2017;103:1111-1116.
    PubMed     Text format     Abstract available


  22. NAIROOZ R, Saad M, Sardar P, Aronow WS, et al
    Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
    Heart. 2017;103:1096-1103.
    PubMed     Text format     Abstract available


  23. BRUGALETTA S, Sabate M
    A longer look at trial evidence of bioresorbable vascular scaffolds.
    Heart. 2017;103:1061-1062.
    PubMed     Text format    


    June 2017
  24. COCKBURN J, Hildick-Smith DJ, Trivedi U, de Belder AJ, et al
    Re: A case for palliative percutaneous coronary intervention.
    Heart. 2017;103:967.
    PubMed     Text format    


  25. BLAKE SR
    A case for palliative percutaneous coronary intervention.
    Heart. 2017;103:967.
    PubMed     Text format    


    April 2017
  26. WILSON SJ, Newby DE, Dawson D, Irving J, et al
    Duration of dual antiplatelet therapy in acute coronary syndrome.
    Heart. 2017;103:573-580.
    PubMed     Text format     Abstract available


  27. NADIR MA
    Inverse prognostic value of post-percutaneous coronary intervention fractional flow reserve in patients with non-ST segment elevation myocardial infarction.
    Heart. 2017;103:564.
    PubMed     Text format    


    March 2017
  28. OPOTOWSKY AR, Baraona FR, Mc Causland FR, Loukas B, et al
    Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
    Heart. 2017;103:434-442.
    PubMed     Text format     Abstract available


  29. CAVALCANTE R, Sotomi Y, Zeng Y, Lee CW, et al
    Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Heart. 2017;103:428-433.
    PubMed     Text format     Abstract available


  30. MOSS AJ, Dweck MR, Flapan AD
    A 33-year-old man with atypical chest pain.
    Heart. 2017;103:474.
    PubMed     Text format     Abstract available


  31. HARBRON RW, Chapple CL, O'Sullivan JJ, Best KE, et al
    Survival adjusted cancer risks attributable to radiation exposure from cardiac catheterisations in children.
    Heart. 2017;103:341-346.
    PubMed     Text format     Abstract available


    February 2017
  32. KIM YY, Rathod RH, Gauvreau K, Keenan EM, et al
    Factors associated with severe aortic dilation in patients with Fontan palliation.
    Heart. 2017;103:280-286.
    PubMed     Text format     Abstract available


  33. LEDWOCH J, Fuernau G, Desch S, Eitel I, et al
    Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock.
    Heart. 2017 Feb 7. pii: heartjnl-2016-310403. doi: 10.1136/heartjnl-2016-310403.
    PubMed     Text format     Abstract available


    January 2017
  34. ALSAIED T, Bokma JP, Engel ME, Kuijpers JM, et al
    Factors associated with long-term mortality after Fontan procedures: a systematic review.
    Heart. 2017;103:104-110.
    PubMed     Text format     Abstract available


  35. DANZI GB, Piccolo R, Chevalier B, Urban P, et al
    Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.
    Heart. 2017;103:111-116.
    PubMed     Text format     Abstract available


  36. VARCOE RW, Clayton TC, Gray HH, de Belder MA, et al
    Impact of call-to-balloon time on 30-day mortality in contemporary practice.
    Heart. 2017;103:117-124.
    PubMed     Text format     Abstract available


  37. CASSESE S, Xhepa E, Kastrati A
    Biodegradable-polymer drug-eluting stents: back to the future?
    Heart. 2017;103:91-92.
    PubMed     Text format    


    December 2016
  38. KIM NH, D'Armini AM, Grimminger F, Grunig E, et al
    Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
    Heart. 2016 Dec 23. pii: heartjnl-2016-309621. doi: 10.1136/heartjnl-2016-309621
    PubMed     Text format     Abstract available


  39. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P, Reiter RJ
    Melatonin for cardioprotection in ST elevation myocardial infarction: are we ready for the challenge?
    Heart. 2016 Dec 7. pii: heartjnl-2016-310689. doi: 10.1136/heartjnl-2016-310689.
    PubMed     Text format    


    November 2016
  40. EISEN A, Bhatt DL
    Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting.
    Heart. 2016 Nov 25. pii: heartjnl-2015-309022. doi: 10.1136/heartjnl-2015-309022
    PubMed     Text format    


    September 2016
  41. JONES DA, Khambata RS, Andiapen M, Rathod KS, et al
    Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention.
    Heart. 2016 Sep 28. pii: heartjnl-2016-309748. doi: 10.1136/heartjnl-2016-309748
    PubMed     Text format     Abstract available


    August 2016
  42. SHAH R, Mooney MA
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335.
    PubMed     Text format    


  43. NAVARESE E, Kowalewski M
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335-6.
    PubMed     Text format    


  44. MCWILLIAMS E, Zehr K, Alshehri A
    An unusual shadow above the aortic valve.
    Heart. 2016 Aug 11. pii: heartjnl-2016-309932. doi: 10.1136/heartjnl-2016-309932
    PubMed     Text format     Abstract available


  45. MANGION K, Carrick D, Hennigan BW, Payne AR, et al
    Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.
    Heart. 2016 Aug 8. pii: heartjnl-2015-308660. doi: 10.1136/heartjnl-2015-308660.
    PubMed     Text format     Abstract available


    July 2016
  46. DI TANO G, Caretta G, De Maria R, Parolini M, et al
    Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Heart. 2016 Jul 27. pii: heartjnl-2016-309673. doi: 10.1136/heartjnl-2016-309673
    PubMed     Text format     Abstract available


  47. PETRONI T, Zaman A, Georges JL, Hammoudi N, et al
    Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians.
    Heart. 2016 Jul 13. pii: heartjnl-2015-308905. doi: 10.1136/heartjnl-2015-308905
    PubMed     Text format     Abstract available


    June 2016
  48. SIZAROV A, Raimondi F, Bonnet D, Boudjemline Y, et al
    Vascular anatomy in children with pulmonary hypertension regarding the transcatheter Potts shunt.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309352. doi: 10.1136/heartjnl-2016-309352
    PubMed     Text format     Abstract available


    May 2016
  49. FUKUI S, Ogo T, Takaki H, Ueda J, et al
    Efficacy of cardiac rehabilitation after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Heart. 2016 May 24. pii: heartjnl-2015-309230. doi: 10.1136/heartjnl-2015-309230
    PubMed     Text format     Abstract available


    March 2016
  50. SHI WY, Yong MS, McGiffin DC, Jain P, et al
    Heart transplantation in Fontan patients across Australia and New Zealand.
    Heart. 2016 Mar 21. pii: heartjnl-2015-308848. doi: 10.1136/heartjnl-2015-308848
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: